Stock THRD THIRD HARMONIC BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Third Harmonic Bio, Inc.

Equities

THRD

US88427A1079

Real-time Estimate Cboe BZX
Other stock markets
 15:43:57 21/05/2024 BST 		5-day change 1st Jan Change
15.04 USD +4.48% Intraday chart for Third Harmonic Bio, Inc. +17.58% +38.38%
05-20 Third Harmonic Bio Insider Sold Shares Worth $331,066, According to a Recent SEC Filing MT
05-15 Third Harmonic Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update
GL
Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors
AQ
Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results
GL
Third Harmonic Bio to Participate in the 44th Annual TD Cowen Health Care Conference
GL
Third Harmonic Bio to Participate in the 44th Annual TD Cowen Health Care Conference
AQ
Purcell & Lefkowitz LLP Announces Shareholder Investigation of Third Harmonic Bio, Inc. (NASDAQ: THRD)
PR
Third Harmonic Bio Appoints Christopher Murphy as Chief Financial and Business Officer and Provides Business Update
GL
Purcell & Lefkowitz LLP Announces Shareholder Investigation of Third Harmonic Bio, Inc. (NASDAQ: THRD)
PR
Third Harmonic Bio Announces Third Quarter 2023 Financial Results
GL
Third Harmonic Bio Announces Third Quarter 2023 Financial Results
AQ
Third Harmonic Bio Announces Leadership Changes
GL
Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference
GL
Third Harmonic Bio Announces Second Quarter 2023 Financial Results
GL
Third Harmonic Bio Announces Second Quarter 2023 Financial Results
AQ
Purcell & Lefkowitz LLP Is Investigating Third Harmonic Bio, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
PR
Third Harmonic Bio Announces Next-Generation Oral KIT Inhibitor Product Candidate THB335
GL
Third Harmonic Bio Announces First Quarter 2023 Financial Results
GL
THIRD HARMONIC BIO, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
AQ
Third Harmonic Bio Announces Fourth Quarter and Year-End 2022 Financial Results
GL
Third Harmonic Bio Announces Fourth Quarter and Year-End 2022 Financial Results
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. THRD Stock
  4. News Third Harmonic Bio, Inc.
  5. Press Releases